Compare ONC & KR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONC | KR |
|---|---|---|
| Founded | 2010 | 1883 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8B | 38.9B |
| IPO Year | N/A | 2007 |
| Metric | ONC | KR |
|---|---|---|
| Price | $317.89 | $68.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $377.33 | $72.58 |
| AVG Volume (30 Days) | 234.7K | ★ 6.1M |
| Earning Date | 01-01-0001 | 03-04-2026 |
| Dividend Yield | N/A | ★ 2.05% |
| EPS Growth | N/A | ★ 23.99 |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $147,123,000,000.00 |
| Revenue This Year | $770.07 | $3.78 |
| Revenue Next Year | $15.48 | $2.10 |
| P/E Ratio | $614.06 | ★ $292.13 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $196.53 | $58.60 |
| 52 Week High | $385.22 | $74.90 |
| Indicator | ONC | KR |
|---|---|---|
| Relative Strength Index (RSI) | 35.71 | 54.85 |
| Support Level | $307.93 | $68.11 |
| Resistance Level | $350.56 | $68.97 |
| Average True Range (ATR) | 10.46 | 2.03 |
| MACD | -4.21 | -0.23 |
| Stochastic Oscillator | 6.49 | 31.23 |
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
Kroger is one of the largest grocery retailers in the United States with about 2,700 stores across a portfolio of more than 20 supermarket banners. The company boasts an ingrained presence in US communities, citing that it is a top-two grocer in most of its major market areas. Over one fourth of Kroger's roughly $110 billion in nonperishable and fresh food sales (about 75% of revenue) stems from its private-label portfolio, of which the company manufactures about 30% of units via its own food production plants. The company also operates fuel stations and pharmacies at 60% and 80% of its locations, respectively.